Biomarkers

Comprehensive Plasma cell-free RNA Profiling for Superior Cancer Detection

Cell Line-Derived Xenografts: A Reliable Platform for Preclinical Cancer Drug Testing

Evolving Frontiers in Immunohistochemistry: Applications and Transformations in Modern Biotechnology

Beyond the Bead: 10 Questions on How to Improve the Reliability of Flow Cytometry Controls with Precision-Engineered Cell Mimics

Reflect on 20 Years of Cancer Research with MIRROR Biospecimens

Tumor Tissue Microarrays (TMAs): A High-Throughput Engine for Cancer Research

Plasma Proteomics: The Next Frontier of Biomarker Discovery in the Precision Medicine Era

#ExpertAnswers: Arutha Kulasinghe on Single-Cell Spatial Phenotyping for Biomarker Discovery

#ExpertAnswers: Mirka Allerding and Anna Sophie Skof on Indivumed Services' Cell-Free Plasma Biobank

#ExpertAnswers: Jeffrey Silva and Matthew Stokes on Mass Spectrometry-Based Proteomics

#ExpertAnswers: Artur Fedorowoski on Cardiovascular Dysautonomia in Post-COVID-19

#ExpertAnswers: Rajendra Kumari and Gera Goverse on the Cancer Immunity Cycle

Industry Insights with Crown Bioscience: In Vitro Technologies for Studying the Cancer-Immunity Cycle

#ExpertAnswers: Bonnie Lun on Single-Domain Antibodies for Research

#ExpertAnswers: Peter Ansell and Marian Navratil on Gene Expression Profiling

#ExpertAnswers: Yuning Chen on Antibody Production

#ExpertAnswers: Anuj Kalsy and Robert Snyder On The Variant-Rich Biobank